A study of gene expression in the living human brain
Liharska, L. E.; Park, Y. J.; Ziafat, K.; Wilkins, L.; Silk, H.; Linares, L. M.; Vornholt, E.; Sullivan, B.; Cohen, V.; Kota, P.; Feng, C.; Cheng, E.; Moya, E.; Thompson, R. C.; Johnson, J. S.; Rieder, M.-K.; Huang, J.; Scarpa, J.; Hashemi, A.; Polanco, J.; Bendl, J.; Hoffman, G. E.; Roussos, P.; Levin, M. A.; Nadkarni, G. N.; Sebra, R.; Crary, J.; Sklar, P.; Schadt, E. E.; Beckmann, N. D.; Kopell, B. H.; Charney, A. W.
Show abstract
A goal of medical research is to determine the molecular basis of human brain health and illness. One way to achieve this goal is through observational studies of gene expression in human brain tissue. Due to the unavailability of brain tissue from living people, most such studies are performed using tissue from postmortem brain donors. An assumption underlying this practice is that gene expression in the postmortem human brain is an accurate representation of gene expression in the living human brain. Here, this assumption - which, until now, had not been adequately tested - is tested by comparing human prefrontal cortex gene expression between 275 living samples and 243 postmortem samples. Expression levels differed significantly for nearly 80% of genes, and a systematic examination of alternative explanations for this observation determined that these differences are not a consequence of cell type composition, RNA quality, postmortem interval, age, medication, morbidity, symptom severity, tissue pathology, sample handling, batch effects, or computational methods utilized. Analyses integrating the data generated for this study with data from earlier landmark studies that used tissue from postmortem brain donors showed that postmortem brain gene expression signatures of neurological and mental illnesses, as well as of normal traits such as aging, may not be accurate representations of these gene expression signatures in the living brain. By using tissue from large cohorts living people, future observational studies of human brain biology have the potential to (1) determine the medical research questions that can be addressed using postmortem tissue as a proxy for living tissue and (2) expand the scope of medical research to include questions about the molecular basis of human brain health and illness that can only be addressed in living people (e.g., "What happens at the molecular level in the brain as a person experiences an emotion?").
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Transient peripheral blood transcriptomic response to ketamine treatment in children with ADNP syndrome 94%
- A role for astrocytic miR-129-5p in Frontotemporal Dementia 94%
- Meta-analysis of the brain transcriptomes of multiple genetic mouse models of schizophrenia highlights dysregulation in striatum and thalamus 93%
Similar papers in this journal
- Evidence for GRN as part of a neuroinflammatory mechanism connecting common neurodegenerative diseases. 94%
- Evidence that minocycline treatment confounds the interpretation of neurofilament as a biomarker 93%
- Disrupted functional brain network associated with presence of hallucinations in Parkinson’s Disease 93%
Similar papers in this journal
- MHCII reduction is insufficient to protect mice from alpha-synuclein-induced degeneration and the Parkinson's HLA locus exhibits epigenetic regulation 95%
- Modeling of mitochondrial genetic polymorphisms reveals induction of heteroplasmy by pleiotropic disease locus MT:10398A>G 93%
- Co-localized SNPs Affecting the Expression of Taste Perception Genes are linked to Alzheimer's Disease 92%
Similar papers in this journal
- Neuronal Dot1l is a broad mitochondrial gene-repressor associated with human brain aging via H3K79 hypermethylation 94%
- Characterization of isolated human astrocytes from aging brain 92%
- Transcriptional and Histone acetylation changes associated with CRE elements expose key factors governing the regulatory circuit in early stage of Huntington's disease models. 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.